MGI at the 14th AORTIC International Cancer Conference in Senegal
11/2/23
11/6/23
Offline
Dakar, Senegal
Share
From November 2nd to 6th, 2023, Dakar, Senegal played host to the 14th AORTIC International Conference on Cancer, and MGI was proud to be an exhibitor at this significant event.
Bringing together multidisciplinary specialists from the African and global cancer community, the conference aimed to support evidence-based interventions and innovative programs focused on the prevention and control of cancer in Africa.
Our local team was on hand to connect with attendees, sharing insights into MGI's mission to lead life science innovation. We engaged in discussions on how our cutting-edge technologies can elevate NGS research and diagnostic capabilities, pushing the boundaries of possibilities in the field.
For those who may have missed the event, detailed information about the conference and its program can be found here.
We extend our sincere thanks to everyone who visited our booth, contributing to insightful discussions and fostering collaboration. We look forward to future opportunities and collaborations that will continue our journey in the pursuit of innovation and progress in the field of life sciences.
From November 2nd to 6th, 2023, Dakar, Senegal played host to the 14th AORTIC International Conference on Cancer, and MGI was proud to be an exhibitor at this significant event.
Bringing together multidisciplinary specialists from the African and global cancer community, the conference aimed to support evidence-based interventions and innovative programs focused on the prevention and control of cancer in Africa.
Our local team was on hand to connect with attendees, sharing insights into MGI's mission to lead life science innovation. We engaged in discussions on how our cutting-edge technologies can elevate NGS research and diagnostic capabilities, pushing the boundaries of possibilities in the field.
For those who may have missed the event, detailed information about the conference and its program can be found here.
We extend our sincere thanks to everyone who visited our booth, contributing to insightful discussions and fostering collaboration. We look forward to future opportunities and collaborations that will continue our journey in the pursuit of innovation and progress in the field of life sciences.
From November 2nd to 6th, 2023, Dakar, Senegal played host to the 14th AORTIC International Conference on Cancer, and MGI was proud to be an exhibitor at this significant event.
Bringing together multidisciplinary specialists from the African and global cancer community, the conference aimed to support evidence-based interventions and innovative programs focused on the prevention and control of cancer in Africa.
Our local team was on hand to connect with attendees, sharing insights into MGI's mission to lead life science innovation. We engaged in discussions on how our cutting-edge technologies can elevate NGS research and diagnostic capabilities, pushing the boundaries of possibilities in the field.
For those who may have missed the event, detailed information about the conference and its program can be found here.
We extend our sincere thanks to everyone who visited our booth, contributing to insightful discussions and fostering collaboration. We look forward to future opportunities and collaborations that will continue our journey in the pursuit of innovation and progress in the field of life sciences.
From November 2nd to 6th, 2023, Dakar, Senegal played host to the 14th AORTIC International Conference on Cancer, and MGI was proud to be an exhibitor at this significant event.
Bringing together multidisciplinary specialists from the African and global cancer community, the conference aimed to support evidence-based interventions and innovative programs focused on the prevention and control of cancer in Africa.
Our local team was on hand to connect with attendees, sharing insights into MGI's mission to lead life science innovation. We engaged in discussions on how our cutting-edge technologies can elevate NGS research and diagnostic capabilities, pushing the boundaries of possibilities in the field.
For those who may have missed the event, detailed information about the conference and its program can be found here.
We extend our sincere thanks to everyone who visited our booth, contributing to insightful discussions and fostering collaboration. We look forward to future opportunities and collaborations that will continue our journey in the pursuit of innovation and progress in the field of life sciences.
About MGI
MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.
MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.
The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.
For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.
About MGI
MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.
MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.
The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.
For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.
About MGI
MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.
MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.
The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.
For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.
About MGI
MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.
MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.
The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.
For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.
GENOMICS
CANCER DIAGNOSTICS
SEQUENCING
NGS
AORTIC 2023
Share this article :
Share
Sep 10, 2024
MGI Tech Unveils its SEQ ALL landscape at the Future of Omics Conference
Discover insights from the "Future of Omics" event, where leading experts discussed innovations in genomics, proteomics, and metabolomics. Explore key takeaways on advancing research and technology, shaping the future of personalized medicine and healthcare. Join us in celebrating the progress in omics!
Jun 1, 2024
MGI Tech Shares New Data on Core DNEBSEQ Technology and Showcases Latest Sequencing Innovations at ESHG 2024
MGI showcased its latest innovations at the ESHG 2024, highlighting the upgraded StandardMPS 2.0 sequencing chemistry and unveiling the new DNBelab C-TaiM 4 Single-Cell Droplet Generator. European researchers presented advancements in diagnostics, population health, and more.
Apr 27, 2024
MGI Showcases New DNBSEQ-E25 Sequencer & Partners with ABL Diagnostics at ESCMID Global 2024
MGI introduced its portable DNBSEQ-E25 sequencer at ESCMID Global 2024, designed for mobile and efficient genomic sequencing with applications in infectious diseases. Additionally, MGI announced a partnership with ABL Diagnostics to integrate DeepChek® assays into its platforms, broadening NGS solutions for microbiology labs.
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).